Aclaris Therapeutics Inc (ACRS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

640 LEE ROAD WAYNE, PA 19087

Aclaris Therapeutics, Inc. operates as a clinical-stage specialty pharmaceutical company. The Company focuses on identifying, developing, and commercializing topical drugs to address significant unmet needs in dermatology. Aclaris Therapeutics offers a topical therapy for the treatment of seborrheic keratosis and other verrucoid lesions of the skin.

Data as of 2021-02-20 14:05:16 -0500
Market Cap909.889 Million Shares Outstanding42.919 Million Avg 30-day Volume1.078 Million
P/E Ratio-16.12249 Dividend Yield0.0 EPS-1.34
Price/Sales-376.48 Debt to Equity1.76 EBITDA-38.364 Million
Price to Book Value25.49 Forward PE Enterprise Value996.212 Million
Total Cash53.477 Million Current Debt12.788 Million Gross Profit-4.356 Million
BETA0.91013 52-week High/Low25.48 / 0.7 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ACRS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 1 200.0% 2 (0.12%) 0 (0.0%)
Funds Holding: 81 58 39.66% 39 (2.35%) 25 (1.56%) 56.0%
13F shares: 31.91 Million 25.554 Million 24.87% 24.715 Million 21.215 Million 16.5%
% Ownership 74.3487 59.5405 24.87% 57.586 49.4289 16.5%
New Positions: 30 5 500.0% 17 3 466.67%
Increased Positions 15 12 25.0% 7 7 0.0%
Closed Positions 7 10 -30.0% 3 4 -25.0%
Reduced Positions 22 22 0.0% 12 9 33.33%
Total Calls 472.525 Thousand 26.6 Thousand 1676.41% 450.9 Thousand 14.3 Thousand 3053.15%
Total Puts 37.105 Thousand 506 7233.0% 14.3 Thousand
PUT/CALL Ratio 0.08 0.02 300.0% 0.03 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Aclaris Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding ACRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACRS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

33.2 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

FORESITE CAPITAL MANAGEMENT IV, LLC

FORESITE CAPITAL FUND IV, L.P.

FORESITE CAPITAL MANAGEMENT V, LLC

FORESITE CAPITAL FUND V, L.P.

TANANBAUM JAMES B.

  • 10% Owner
 6,612,181 2021-02-05 1

MEHRA ANAND

  • Director
 30,841 2021-02-02 3

ALI-JACKSON KAMIL CHIEF LEGAL OFFICER

  • Officer
 126,646 2021-02-01 4

RUFFO FRANK CHIEF FINANCIAL OFFICER

  • Officer
 215,189 2021-02-01 4

WALKER NEAL PRESIDENT AND CEO

  • Officer
  • Director
 1,155,798 2021-02-01 5

GORDON DAVID N. CHIEF MEDICAL OFFICER

  • Officer
 87,535 2020-07-02 3

MOLINEAUX CHRISTOPHER P.

  • Director
 23,891 2020-06-04 2

HUMPHRIES WILLIAM D.

  • Director
 16,209 2020-06-04 2

POWELL ANDREW KENNETH WILLIAM

  • Director
 16,709 2020-06-04 2

SCHIFF ANDREW N

  • Director
 650,664 2020-06-04 2

REASONS BRYAN M.

  • Director
 16,209 2020-06-04 2

GOWEN MAXINE

  • Director
 0 2020-06-04 2

MILANO VINCENT

  • Director
 0 2020-06-04 1

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF A 10% GROUP
4,123,266 2019-06-27 0

SHANLER STUART CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2019-03-01 0

POWALA CHRISTOPHER CHIEF REG & DEVELOP OFFICER

  • Officer
 272,163 2019-02-01 0

FAIR BRETT CHIEF COMMERCIAL OFFICER

  • Officer
 10,582 2019-02-01 0

TULLMAN STEPHEN A.

  • Director
 571,471 2018-10-04 0

FMR LLC

  • SEE REMARK 1
 No longer subject to file 2017-08-21 0

BIERLY RICK

  • Director
 0 2017-06-15 0

VIVO VENTURES VII, LLC

VIVO VENTURES FUND VII, L.P.

VIVO VENTURES VII AFFILIATES FUND, L.P.

  • 10% Owner
 8,925,707 2017-02-28 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

RA CAPITAL HEALTHCARE FUND LP

  • 10% Owner
 No longer subject to file 2016-09-15 0

CHA ALBERT

  • Director
 0 2016-06-29 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • 10% Owner
 2,314,942 2015-10-19 0

SOFINNOVA VENTURE PARTNERS VIII, L.P.

SOFINNOVA MANAGEMENT VIII, L.L.C.

HEALY JAMES

AKKARAJU SRINIVAS

POWELL MICHAEL

  • 10% Owner
 2,289,480 2015-10-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MEHRA ANAND - Director

2021-02-03 17:33:10 -0500 2021-02-02 M 8,000 d 0 direct

MEHRA ANAND - Director

2021-02-03 17:33:10 -0500 2021-02-02 M 6,632 $18.32 a 30,841 direct

MEHRA ANAND - Director

2021-02-03 17:33:10 -0500 2021-02-02 M 6,632 d 0 direct

MEHRA ANAND - Director

2021-02-03 17:33:10 -0500 2021-02-02 M 8,000 $18.35 a 24,209 direct

WALKER NEAL - Director - Officer PRESIDENT AND CEO

2021-02-03 17:23:56 -0500 2021-02-01 M 10,800 a 1,159,114 direct

RUFFO FRANK - Officer CHIEF FINANCIAL OFFICER

2021-02-03 17:29:24 -0500 2021-02-01 M 3,875 d 3,875 direct

ALI-JACKSON KAMIL - Officer CHIEF LEGAL OFFICER

2021-02-03 17:26:46 -0500 2021-02-01 M 3,875 d 3,875 direct

WALKER NEAL - Director - Officer PRESIDENT AND CEO

2021-02-03 17:23:56 -0500 2021-02-01 M 10,800 d 10,800 direct

RUFFO FRANK - Officer CHIEF FINANCIAL OFFICER

2021-02-03 17:29:24 -0500 2021-02-01 F 1,308 $21.35 d 215,189 direct

ALI-JACKSON KAMIL - Officer CHIEF LEGAL OFFICER

2021-02-03 17:26:46 -0500 2021-02-01 F 1,318 $21.35 d 126,646 direct

WALKER NEAL - Director - Officer PRESIDENT AND CEO

2021-02-03 17:23:56 -0500 2021-02-01 F 3,316 $21.35 d 1,155,798 direct

RUFFO FRANK - Officer CHIEF FINANCIAL OFFICER

2021-02-03 17:29:24 -0500 2021-02-01 M 3,875 a 216,497 direct

ALI-JACKSON KAMIL - Officer CHIEF LEGAL OFFICER

2021-02-03 17:26:46 -0500 2021-02-01 M 3,875 a 127,964 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 22:15:02 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 21:45:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 21:15:02 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 20:45:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 20:15:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 19:45:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 19:15:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 18:45:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 18:15:02 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 17:45:02 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 17:15:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 16:45:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 16:15:02 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 15:45:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 15:15:03 UTC -1.5065 1.5765 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 14:45:03 UTC -0.6129 0.6829 450000
ACLARIS THERAPEUTICS INC ACRS 2021-02-26 13:00:03 UTC -0.6129 0.6829 400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments